secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001493152-26-006837
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative raises $5.0M in public offering of stock and warrants to fund clinical programs
--------------------------------------------------------------------------------

- Offering of 14.3M shares (or pre-funded warrants) and 14.3M five-year warrants at $0.35/unit closed Feb 13.
- Gross proceeds ~$5.0M net of ~7% placement agent fee and expenses.
- Proceeds to fund BRTX-100 Phase 2 trial, ThermoStem R&D, biocosmeceuticals platform, and working capital.
- Rodman & Renshaw acted as exclusive placement agent; 90-day lockup on new equity issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000149315226006837/0001493152-26-006837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000149315226006837/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-006837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer